跳至主要内容
临床试验/EUCTR2014-003874-17-IT
EUCTR2014-003874-17-IT进行中(未招募)1 期

Antiretroviral Pre-exposure prophylaxis for natural conception (PrEP-C) in serodiscordant female partners of HIV-infected men in sustained virologic suppression

ational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS0 个研究点目标入组 30 人开始时间: 2014年9月26日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Age> 18 years (couple)
  • HIV infected male partner on ARV treatment with plasma HIV RNA <40 copies / mL for at least 6 months
  • Test HIVAb / Ag negative (female partner)
  • No unprotected sex with HIV infected partner (female partner) or with other partners (couple) in the last 30 days
  • Absence of sexually transmitted disease or infection (couple)
  • Signing of Informed Consent (couple).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Female partner:
  • Hepatitis B or nephropathy
  • Presence of contraindications for Truvada as specified in the leaflet indications
  • Use of psychoactive substances that may interfere with the patient's adherence to the prescribed medication regimen
  • Participation in other Clinical Trial
  • Subjects who, in the opinion of the investigator, does not ensure appropriate adherence to the study
  • Inability to sign the informed consent.
  • Signature of consent only by the female partner.

研究者

发起方
ational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS

相似试验